BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $210,214 | -21.0% | 4,614 | -29.7% | 0.02% | -25.0% |
| Q1 2023 | $266,236 | -26.5% | 6,564 | -7.7% | 0.02% | -28.6% |
| Q4 2022 | $362,346 | -5.4% | 7,109 | 0.0% | 0.03% | -12.5% |
| Q3 2022 | $383,000 | -20.4% | 7,109 | -5.0% | 0.03% | -15.8% |
| Q2 2022 | $481,000 | -20.1% | 7,487 | -3.5% | 0.04% | -5.0% |
| Q1 2022 | $602,000 | -32.8% | 7,760 | -25.6% | 0.04% | -31.0% |
| Q4 2021 | $896,000 | +4.3% | 10,433 | -2.3% | 0.06% | +1.8% |
| Q3 2021 | $859,000 | +4.9% | 10,684 | +5.0% | 0.06% | -3.4% |
| Q2 2021 | $819,000 | -5.4% | 10,171 | -1.0% | 0.06% | -13.2% |
| Q1 2021 | $866,000 | -1.1% | 10,271 | -6.0% | 0.07% | -4.2% |
| Q4 2020 | $876,000 | -4.9% | 10,921 | -4.6% | 0.07% | -23.7% |
| Q3 2020 | $921,000 | -8.7% | 11,451 | -2.3% | 0.09% | -14.7% |
| Q2 2020 | $1,009,000 | +4.2% | 11,720 | -1.7% | 0.11% | -13.5% |
| Q1 2020 | $968,000 | -8.6% | 11,920 | -5.9% | 0.13% | +14.5% |
| Q4 2019 | $1,059,000 | -7.6% | 12,661 | -3.4% | 0.11% | -14.7% |
| Q3 2019 | $1,146,000 | +6.0% | 13,100 | -0.8% | 0.13% | +4.0% |
| Q2 2019 | $1,081,000 | +0.1% | 13,200 | -0.6% | 0.12% | -2.4% |
| Q1 2019 | $1,080,000 | +20.4% | 13,285 | -2.6% | 0.13% | +3.3% |
| Q4 2018 | $897,000 | -17.6% | 13,635 | -3.4% | 0.12% | -8.9% |
| Q3 2018 | $1,088,000 | +3.6% | 14,109 | -0.7% | 0.14% | -5.6% |
| Q2 2018 | $1,050,000 | +2.5% | 14,215 | -9.7% | 0.14% | +4.4% |
| Q1 2018 | $1,024,000 | +0.7% | 15,740 | 0.0% | 0.14% | -5.5% |
| Q4 2017 | $1,017,000 | +7.2% | 15,740 | +4.1% | 0.14% | -0.7% |
| Q3 2017 | $949,000 | +2.0% | 15,120 | -1.6% | 0.15% | -5.2% |
| Q2 2017 | $930,000 | +13.7% | 15,365 | -2.5% | 0.15% | +10.8% |
| Q1 2017 | $818,000 | +14.6% | 15,765 | -2.1% | 0.14% | +12.1% |
| Q4 2016 | $714,000 | -6.9% | 16,110 | 0.0% | 0.12% | -11.4% |
| Q3 2016 | $767,000 | +5.4% | 16,110 | 0.0% | 0.14% | +2.2% |
| Q2 2016 | $728,000 | +6.0% | 16,110 | -3.6% | 0.14% | -0.7% |
| Q1 2016 | $687,000 | +0.1% | 16,718 | -7.1% | 0.14% | -4.8% |
| Q4 2015 | $686,000 | +12.6% | 17,993 | -3.0% | 0.14% | +7.4% |
| Q3 2015 | $609,000 | -53.9% | 18,549 | -1.7% | 0.14% | -50.7% |
| Q2 2015 | $1,320,000 | +6.0% | 18,874 | +3.9% | 0.27% | +5.8% |
| Q1 2015 | $1,245,000 | -6.2% | 18,174 | +0.3% | 0.26% | -7.8% |
| Q4 2014 | $1,328,000 | -21.9% | 18,124 | -23.5% | 0.28% | -23.6% |
| Q3 2014 | $1,701,000 | +1.7% | 23,704 | +2.4% | 0.37% | +3.1% |
| Q2 2014 | $1,673,000 | +9.3% | 23,143 | +11.3% | 0.36% | +5.9% |
| Q1 2014 | $1,530,000 | +4.8% | 20,793 | -1.0% | 0.34% | -3.7% |
| Q4 2013 | $1,460,000 | +5.3% | 20,993 | -0.6% | 0.35% | -4.1% |
| Q3 2013 | $1,387,000 | -3.3% | 21,118 | +2.0% | 0.36% | -8.5% |
| Q2 2013 | $1,435,000 | – | 20,711 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SECTOR GAMMA AS | 713,500 | $49,895,000 | 12.74% |
| Veritas Asset Management LLP | 7,636,450 | $534,017,000 | 7.53% |
| FIRST NEW YORK SECURITIES LLC /NY | 154,158 | $10,780,269,000 | 5.40% |
| Gabalex Capital Management LLC | 200,000 | $14,981,000 | 5.39% |
| Veritas Investment Management LLP | 291,825 | $18,816,000 | 5.32% |
| Tweedy, Browne Co LLC | 2,543,966 | $177,900,000 | 4.91% |
| York Capital Management Global Advisors, LLC | 8,074,375 | $564,641,000 | 4.78% |
| First Fiduciary Investment Counsel, Inc. | 270,675 | $18,928,000 | 4.10% |
| SCHARF INVESTMENTS, LLC | 2,247,225 | $157,148,000 | 4.03% |
| Osher Van de Voorde Investment Management | 96,235 | $6,730,000 | 3.91% |